StarDrop 5 – Software for Successful Drug Discovery
25 May 2011
Watch this video to learn about the key features of the new StarDrop 5 software for drug discovery. The software allows you to assess your compounds potential for success against your project’s objectives, compare all your candidate molecules against a weighted profile of required properties to see which are most likely to succeed as well as visualise chemical diversity, identify high quality compounds and create diverse and balanced selections. The Glowing Molecule visualisation shows you the regions of candidate molecules which may have the most influence on predicted properties. Try out new ideas interactively with instant feedback.
About the company

Optibrium
Optibrium is dedicated to providing software to guide decisions involving complex, uncertain data in an intuitive way. Our primary product, StarDrop, is focussed on the drug discovery industry, helping scientists to guide decisions in the design and selection of potential drug molecules.
Optibrium was founded in 2009 as a spin-out of BioFocus DPI (formerly Inpharmatica). The founding group was responsible for the development of StarDrop from 2003 and, prior to this, research and development of related technologies since 1994.
Based in Cambridge, UK, Optibrium has a global customer base ranging from top-10 pharmaceutical companies to small biotechs and academic groups.
